Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B

[1]  W. Brien,et al.  Auto-immune thrombocytopenia related to interferon therapy. , 2009, Scandinavian journal of haematology.

[2]  K. Schmidt,et al.  Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura. , 2009, Scandinavian journal of haematology.

[3]  P. E. Madsen,et al.  Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia. , 2009, Scandinavian journal of haematology.

[4]  A. Peters,et al.  The kinetics of short-lived indium-111 radiolabelled platelets. , 2009, Scandinavian journal of haematology.

[5]  J. Prieto,et al.  Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrom , 1996, Hepatology.

[6]  A. Minty,et al.  IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytes , 1993, FEBS Letters.

[7]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[8]  J. Hoofnagle,et al.  Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. , 1986, The New England journal of medicine.

[9]  H. Kantarjian,et al.  Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients. , 1986, Experimental hematology.

[10]  W. Richtsmeier,et al.  Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells. , 1986, Journal of interferon research.

[11]  P. Ind,et al.  Intrahepatic Kinetics of lndium-111-Labelled Platelets , 1985, Thrombosis and Haemostasis.

[12]  B. Barlogie,et al.  Immune Thrombocytopenia Following α-Interferon Therapy in Patients With Cancer , 1985 .

[13]  J U Gutterman,et al.  Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. , 1985, JAMA.

[14]  S. Russell,et al.  Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. , 1985, Journal of immunology.

[15]  J. Kirkwood,et al.  Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. , 1984, The American journal of medicine.

[16]  D. Birmingham,et al.  Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.

[17]  P. Toghill,et al.  Platelet dynamics in chronic liver disease using the 111Indium oxine label. , 1983, Gut.

[18]  W. Rosse,et al.  Characterization of the IgG-Fc receptor on human platelets , 1982 .

[19]  Neumann Ha,et al.  Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow. , 1982 .

[20]  B. Andersson,et al.  Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. , 1982, Journal of immunology.

[21]  M. Dewanjee,et al.  Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  S. Lewis,et al.  Radionuclide Distribution folowing Injection of 111Indium‐labelled Platelets , 1980, British journal of haematology.

[23]  C. Herbst,et al.  Kinetics and in Vivo Redistribution of 111Indium-Labelled Human Platelets after Intravenous Protamine Sulphate , 1980, Thrombosis and Haemostasis.

[24]  B. Löwenberg,et al.  Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. , 1978, Cancer research.

[25]  M. Welch,et al.  Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. , 1976, Thrombosis research.

[26]  T. Merigan,et al.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. , 1976, The New England journal of medicine.

[27]  H. Beekhuis,et al.  111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia , 2004, European Journal of Nuclear Medicine.

[28]  H. Kawasaki,et al.  Evaluation of the side effects of interferon therapy by questionnaire in chronic hepatitis C. , 1995 .

[29]  青木 義憲.  Mechanism of thrombocytopenia in liver cirrhosis : kinetics of indium-111 tropolone labelled platelets , 1993 .

[30]  A. Ganser,et al.  Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. , 1987, Blood.

[31]  W. Rosse,et al.  Characterization of the IgG-Fc receptor on human platelets. , 1982, Blood.

[32]  A. Fauser,et al.  Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow. , 1982, Experimental hematology.